MDRNA develops RNAi therapeutics

History:

MDRNA was founded as Nastech Pharmaceutical. After changing their focus to RNAi therapeutics, they changed their name to MDRNA. They subsequently changed their name to Marina Biotech after their acquisition of Cequent Pharmaceuticals in 2010.

Acquisitions:
Cequent Pharmaceuticals (2010)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Pacific Northwest

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: